image-title

ICH E6 (R2) requires sponsors to maintain responsibility for oversight of vendors, including those handling your clinical trial data. This often is challenging, particularly for companies with limited or no biometrics departments internally. Correct and effective data oversight increases your confidence in your clinical trial results and supports progress of development programs. During this webinar, we will review the components of biometrics oversight, assess various approaches, suggest an effective data oversight strategy and present case studies. The key learning outcomes will be:

• Understanding of the importance of oversight for clinical trial data

• How to choose the right approach to data oversight

• What are the fundamental components of an oversight program

For more information click here

OACTIVEAdmin

OACTIVEAdmin has blogged 710 posts

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. More Info

Cookies are small text files held on your computer. Some cookies are required to ensure that the site functions correctly, for this reason we may have already set some cookies. They also allow us to give you the best browsing experience possible and help us understand how you use our site. For more information read our Privacy Policy.

Close